Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1380

1.

Efficacy and safety of Colchicine in inflammatory skin diseases: a retrospective, monocentric study in a large tertiary center.

Anzengruber F, Graf V, Hafner J, Meienberer N, Guenova E, Dummer R.

J Dermatolog Treat. 2019 Nov 7:1-25. doi: 10.1080/09546634.2019.1690621. [Epub ahead of print]

PMID:
31694429
2.

Nanoparticle-coupled topical methotrexate can normalize immune responses and induce tissue remodeling in psoriasis.

Özcan A, Sahin D, Impellizzieri D, Nguyen TT, Hafner J, Yawalkar N, Kurzbach D, Tan G, Akdis CA, Nilsson J, Boyman O, Kolios AGA.

J Invest Dermatol. 2019 Oct 30. pii: S0022-202X(19)33373-1. doi: 10.1016/j.jid.2019.09.018. [Epub ahead of print]

PMID:
31678057
3.

Correction to: Nrf3 promotes UV-induced keratinocyte apoptosis through suppression of cell adhesion.

Siegenthaler B, Defila C, Muzumdar S, Beer HD, Meyer M, Tanner S, Bloch W, Blank V, Schäfer M, Werner S.

Cell Death Differ. 2019 Oct 22. doi: 10.1038/s41418-019-0437-z. [Epub ahead of print]

PMID:
31641240
4.

Risk factors for severe systemic sting reactions in wasp (Vespula spp.) and honeybee (Apis mellifera) venom allergic patients.

Fehr D, Micaletto S, Moehr T, Schmid-Grendelmeier P.

Clin Transl Allergy. 2019 Oct 11;9:54. doi: 10.1186/s13601-019-0292-5. eCollection 2019.

5.

Identifying and managing patients at risk of severe allergic reactions to food: report from two iFAAM workshops.

Roberts G, Allen K, Ballmer-Weber B, Clark A, Crevel R, Dunn Galvin A, Fernandez-Rivas M, Grimshaw KEC, Hourihane JO, Poulsen LK, van Ree R, Regent L, Remington B, Schnadt S, Turner PJ, Mills ENC.

Clin Exp Allergy. 2019 Oct 20. doi: 10.1111/cea.13516. [Epub ahead of print]

PMID:
31631439
6.

Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted Therapy.

Dimitriou F, Mangana J, Dummer R.

Acta Derm Venereol. 2019 Oct 18. doi: 10.2340/00015555-3355. [Epub ahead of print] No abstract available.

7.

Inhibition of p38/MK2 signaling prevents vascular invasion of melanoma.

Wenzina J, Holzner S, Puujalka E, Cheng PF, Forsthuber A, Neumüller K, Schossleitner K, Lichtenberger BM, Levesque MP, Petzelbauer P.

J Invest Dermatol. 2019 Oct 14. pii: S0022-202X(19)33299-3. doi: 10.1016/j.jid.2019.08.451. [Epub ahead of print]

PMID:
31622599
8.

Observer-independent assessment of psoriasis affected area using machine learning.

Meienberger N, Anzengruber F, Amruthalingam L, Christen R, Koller T, Maul JT, Pouly M, Djamei V, Navarini AA.

J Eur Acad Dermatol Venereol. 2019 Oct 8. doi: 10.1111/jdv.16002. [Epub ahead of print]

PMID:
31594034
9.

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172).

Schadendorf D, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R, Grigoryeva E, Young TC, Nathan P.

Eur J Cancer. 2019 Nov;121:144-153. doi: 10.1016/j.ejca.2019.08.014. Epub 2019 Sep 30.

PMID:
31581055
10.

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

Michielin O, van Akkooi A, Ascierto P, Dummer R, Keilholz U; ESMO Guidelines Committee.

Ann Oncol. 2019 Sep 30. pii: mdz411. doi: 10.1093/annonc/mdz411. [Epub ahead of print] No abstract available.

PMID:
31566661
11.

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, Cowey CL, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Hogg D, Hill A, Márquez-Rodas I, Haanen J, Guidoboni M, Maio M, Schöffski P, Carlino MS, Lebbé C, McArthur G, Ascierto PA, Daniels GA, Long GV, Bastholt L, Rizzo JI, Balogh A, Moshyk A, Hodi FS, Wolchok JD.

N Engl J Med. 2019 Oct 17;381(16):1535-1546. doi: 10.1056/NEJMoa1910836. Epub 2019 Sep 28.

PMID:
31562797
12.

Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry.

Cazzaniga S, Anzengruber F, Augustin M, Boehncke WH, Borradori L, Conrad C, Cozzio A, Djamei V, French LE, Gilliet M, Häusermann P, Heidemeyer K, Itin P, Kolios AGA, Laffitte E, Maul JT, Mainetti C, Naldi L, Navarini AA, Rustenbach SJ, Simon D, Sorbe C, Streit M, Yawalkar N.

J Eur Acad Dermatol Venereol. 2019 Sep 28. doi: 10.1111/jdv.15983. [Epub ahead of print]

PMID:
31562785
13.

Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives.

Bobrowicz M, Zagozdzon R, Domagala J, Vasconcelos-Berg R, Guenova E, Winiarska M.

Cancers (Basel). 2019 Sep 24;11(10). pii: E1420. doi: 10.3390/cancers11101420. Review.

14.

Geographical and Ethnic Differences Influence Culturable Commensal Yeast Diversity on Healthy Skin.

Leong C, Schmid B, Toi MJ, Wang J, Irudayaswamy AS, Goh JPZ, Bosshard PP, Glatz M, Dawson TL Jr.

Front Microbiol. 2019 Aug 27;10:1891. doi: 10.3389/fmicb.2019.01891. eCollection 2019.

15.

Accuracy of PCR and serological testing for the diagnosis of primary syphilis: Both tests are necessary.

Noda AA, Rodríguez I, Grillová L, Bosshard PP, Lienhard R.

Int J STD AIDS. 2019 Sep 24:956462419859764. doi: 10.1177/0956462419859764. [Epub ahead of print] No abstract available.

PMID:
31551003
16.

A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanoma.

Nagler A, Vredevoogd DW, Alon M, Cheng PF, Trabish S, Kalaora S, Arafeh R, Goldin V, Levesque MP, Peeper DS, Samuels Y.

Pigment Cell Melanoma Res. 2019 Sep 24. doi: 10.1111/pcmr.12825. [Epub ahead of print]

PMID:
31549767
17.

Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase 2 randomised, double-blind BOLT study.

Dummer R, Guminksi A, Gutzmer R, Lear JT, Lewis KD, Chang ALS, Combemale P, Dirix L, Kaatz M, Kudchadkar R, Loquai C, Plummer R, Schulze HJ, Stratigos AJ, Trefzer U, Squittieri N, Migden MR.

Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18552. [Epub ahead of print]

PMID:
31545507
18.

Prdx4 limits caspase-1 activation and restricts inflammasome-mediated signaling by extracellular vesicles.

Lipinski S, Pfeuffer S, Arnold P, Treitz C, Aden K, Ebsen H, Falk-Paulsen M, Gisch N, Fazio A, Kuiper J, Luzius A, Billmann-Born S, Schreiber S, Nuñez G, Beer HD, Strowig T, Lamkanfi M, Tholey A, Rosenstiel P.

EMBO J. 2019 Oct 15;38(20):e101266. doi: 10.15252/embj.2018101266. Epub 2019 Sep 23.

19.

Management of allergy transfer upon solid organ transplantation.

Muller YD, Vionnet J, Beyeler F, Eigenmann P, Caubet JC, Villard J, Berney T, Scherer K, Spertini F, Fricker MP, Lang C, Schmid-Grendelmeier P, Benden C, Roux Lombard P, Aubert V, Immer F, Pascual M, Harr T; Swiss Transplant Cohort Study.

Am J Transplant. 2019 Sep 18. doi: 10.1111/ajt.15601. [Epub ahead of print]

PMID:
31535461
20.

SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1-Nrf2.

Burgener AV, Bantug GR, Meyer BJ, Higgins R, Ghosh A, Bignucolo O, Ma EH, Loeliger J, Unterstab G, Geigges M, Steiner R, Enamorado M, Ivanek R, Hunziker D, Schmidt A, Müller-Durovic B, Grählert J, Epple R, Dimeloe S, Lötscher J, Sauder U, Ebnöther M, Burger B, Heijnen I, Martínez-Cano S, Cantoni N, Brücker R, Kahlert CR, Sancho D, Jones RG, Navarini A, Recher M, Hess C.

Nat Immunol. 2019 Oct;20(10):1311-1321. doi: 10.1038/s41590-019-0482-2. Epub 2019 Sep 16.

PMID:
31527833

Supplemental Content

Loading ...
Support Center